Marc R. Schneebaum

2019

In 2019, Marc R. Schneebaum earned a total compensation of $3.5M as Senior Vice President, Chief Financial Officer at Synta Pharmaceuticals, a 5% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$223,298
Option Awards$2,868,320
Salary$421,000
Other$20,034
Total$3,532,652

Schneebaum received $2.9M in option awards, accounting for 81% of the total pay in 2019.

Schneebaum also received $223.3K in non-equity incentive plan, $421K in salary and $20K in other compensation.

Rankings

In 2019, Marc R. Schneebaum's compensation ranked 3,437th out of 13,971 executives tracked by ExecPay. In other words, Schneebaum earned more than 75.4% of executives.

ClassificationRankingPercentile
All
3,437
out of 13,971
75th
Division
Manufacturing
1,246
out of 5,701
78th
Major group
Chemicals And Allied Products
428
out of 2,200
81st
Industry group
Drugs
356
out of 1,886
81st
Industry
Pharmaceutical Preparations
268
out of 1,398
81st

Pay ratio

Marc R. Schneebaum's Pay$3,532,652
Median Employee's Pay$791,000
Pay Ratio

4

to 1

In 2019, the annual total compensation of Marc R. Schneebaum was $3,532,652.

The annual total compensation of the median employee at Synta Pharmaceuticals was $791,000.

The ratio of Marc R. Schneebaum's pay to the pay of median employee was therefore 4 to one.

Source: SEC filing on April 29, 2020.

Schneebaum's colleagues

We found four more compensation records of executives who worked with Marc R. Schneebaum at Synta Pharmaceuticals in 2019.

2019

Paul Friedman

Synta Pharmaceuticals

Chief Executive Officer

2019

Rebecca Taub

Synta Pharmaceuticals

Chief Medical Officer

2019

Brian Lynch

Synta Pharmaceuticals

General Counsel

2019

Brian Lynch

Synta Pharmaceuticals

General Counsel

News

In-depth

You may also like